Medical Research News

RSS

NIAID announces 14 grants for basic research to identify new HIV vaccine approaches

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded 14 grants totaling $7.8 million in first-year funding for basic research to identify new approaches for designing a safe and effective HIV vaccine.

22 Aug 2012

HDL cholesterol benefits reduced with high C-reactive protein

The cardioprotective effects of high-density lipoprotein cholesterol are compromised in the presence of elevated high-sensitivity C-reactive protein, report researchers.

21 Aug 2012

Vitamin D may help fight childhood acute respiratory infections

Supplementation with vitamin D, particularly in winter, appears to reduce a child’s risk for contracting acute respiratory infections by almost 50%, show results from a Mongolian study.

21 Aug 2012

Stem-cell therapy holds promise for postinjury arthritis prevention

A novel stem-cell treatment may hold the key to treating osteoarthritis triggered by joint injury, suggest results from an animal study.

21 Aug 2012

Highly sensitive troponin assay shortens heart attack diagnosis

An algorithm that incorporates high-sensitivity cardiac troponin could allow accurate rule-in and rule-out of patients with acute chest pain within 1 hour of presentation, a study shows.

21 Aug 2012

Childhood asthma link shows it is never too soon for mums to quit smoking

Smoking during pregnancy increases the risk for asthma and wheezing in early childhood, even if children are not exposed to smoke after birth, a European study shows.

21 Aug 2012

Social phobia prevalent in OCD patients

Social phobia is common among patients with obsessive compulsive disorder and frequently co-occurs with other related disorders, researchers report.

21 Aug 2012

Deep abdominal muscle activation lessens lower back pain

Improving transversus abdominis slide appears to be associated with clinically important long-term pain reduction in people experiencing lower back pain, researchers report.

21 Aug 2012

CKD may raise stroke, bleeding risk in AF patients

Danish study results show that the presence of chronic kidney disease appears to raise the risk for stroke, systemic thromboembolism, and bleeding among patients with atrial fibrillation.

21 Aug 2012

Genetic key to severe malaria resistance uncovered

Researchers have identified two genetic variants linked with human resistance to severe malaria.

21 Aug 2012

International guidelines improve outcomes after dental trauma

Adhering to the current International Association of Dental Traumatology guidelines for emergency treatment and care of traumatized teeth results in significantly lower complication rates, report researchers in Clinical Oral Investigations.

21 Aug 2012

CHD patients do not need to rule out high-intensity exercise

Findings from a retrospective study show that patients with coronary heart disease who engage in high-intensity exercise have a similarly low risk for a cardiovascular event as those engaging in moderate-intensity exercise.

21 Aug 2012

Sore throat treatment should be individually tailored

Throat discomfort may have a variety of causes and a range of symptoms, all of which should be considered before decisions about treatment are made, report researchers.

21 Aug 2012

Gene therapy applied to peripheral arterial disease

Hepatocyte growth factor gene therapy could be used to treat patients with severe peripheral arterial disease, suggest results of a phase I clinical trial.

21 Aug 2012

Interhemispheric coordination reduced in schizophrenia

Results from a US study show that patients with schizophrenia have significantly decreased interhemispheric coordination compared with mentally healthy individuals.

21 Aug 2012

Impulsiveness linked to bipolar disorder severity

Trait impulsiveness is associated with a severe course of bipolar disorder, researchers report.

21 Aug 2012

Bile duct cancer chosen as next indication for PCI Biotech

PCI Biotech (PCIB) the Norwegian biopharmaceutical company, reported today that it has chosen bileduct cancer as the next indication for the use of its PCI (photochemical internalisation) localised cancer therapy. In this indication PCI Biotech’s proprietary photosensitiser Amphinex® will be used in combination with the generic cytotoxic agent gemcitabine. The aim is to start the clinical Proof of Concept study within end of 1H 2013.

21 Aug 2012